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Toll-like receptor 2 (TLR2) initiates potent immune
responses by recognizing diacylated and triacylated
lipopeptides. Its ligand specificity is controlled by
whether it heterodimerizes with TLR1 or TLR6. We
have determined the crystal structures of TLR2-
TLR6-diacylated lipopeptide, TLR2-lipoteichoic acid,
andTLR2-PE-DTPAcomplexes.PE-DTPA,1,2-dimyr-
istoyl-sn-glycero-3-phosphoethanolamine-N-diethy-
lenetriaminepentaacetic acid, is a synthetic phos-
pholipid derivative. Two major factors contribute to
the ligand specificity of TLR2-TLR1 or TLR2-TLR6
heterodimers. First, the lipid channel of TLR6 is
blocked by two phenylalanines. Simultaneous muta-
tion of these phenylalanines made TLR2-TLR6 fully
responsive not only to diacylated but also to triacy-
lated lipopeptides. Second, the hydrophobic dimer-
ization interface of TLR2-TLR6 is increased by 80%,
which compensates for the lack of amide lipid
interaction between the lipopeptide and TLR2-
TLR6. The structures of the TLR2-lipoteichoic acid
and the TLR2-PE-DTPA complexes demonstrate
that a precise interaction pattern of the head group
is essential for a robust immune response by TLR2
heterodimers.INTRODUCTION
Toll-like receptor (TLR) family proteins play a central role in the
innate immune system by recognizing common patterns in
diverse microbial molecules (Gay and Gangloff, 2007). TLR2,
one of ten human TLRs, recognizes lipoproteins that are
anchored to the bacterial membrane by lipid chains covalently
attached to conserved N-terminal cysteines (Hantke and Braun,
1973). Lipoproteins fromGram-negative bacteria have three lipid
chains; two of them are attached by ester bonds to a glycerolIbackbone that is in turn connected to the sulfur atom of the N-
terminal cysteine. The third lipid chain is connected to the amino
termini via amide bonds. Lipoproteins from Gram-positive
bacteria or mycoplasmas often have only two lipid chains
because they lack the amide-linked lipid chain (Muhlradt et al.,
1997; Shibata et al., 2000). Synthetic lipopeptide analogs con-
taining di- or triacylated cysteine groupsmimic the proinflamma-
tory properties of lipoproteins, thus confirming that the acylated
N-terminal cysteine is the principal immune stimulatory motif
(Bessler et al., 1985). The ligand-binding specificity of TLR2 is
modulated by its heterodimerization partners. Macrophages
from TLR1-deficient mice are stimulated by diacylated lipopro-
teins but not by triacylated lipoproteins (Takeuchi et al., 2002).
In contrast, macrophages from TLR6-deficient mice cannot be
activated by diacylated lipopeptides such as MALP-2 (Takeuchi
et al., 2001). TLR2 has been shown to be activated by many
microbial products in addition to lipoproteins, including lipotei-
choic acids, lipomannans, peptidoglycans, zymosans, and
phenol-soluble modulins (Zahringer et al., 2008).
Recently, the extracellular domains of several TLRs with and
without bound ligands have been crystallized and their struc-
tures have been reported (Bell et al., 2005; Choe et al., 2005;
Jin et al., 2007; Kim et al., 2007b; Liu et al., 2008; Park et al.,
2009). These structures, as well as sequence conservation
data, demonstrate that TLRs belong to the leucine-rich repeat
(LRR) family and form characteristic, horseshoe-like structures
(Matsushima et al., 2007). The vast majority of LRR family
proteins interact with protein ligands by their concave surfaces
(Bella et al., 2008). TLRs are exceptions to this rule because
most of them interact with nonprotein ligands, using their lateral
or convex surfaces (Jin and Lee, 2008). TLR family proteins show
little similarity in their ligand interactions. Triacylated lipopepti-
des interact with hydrophobic pockets in TLR1 and TLR2, by
using the three lipid chains that bridge the two TLRs for hetero-
dimerization (Jin et al., 2007). Double-stranded RNA induces ho-
modimerization of TLR3 by interacting with its lateral surfaces
(Liu et al., 2008). TLR4 does not directly interact with ligands;
instead, it forms a heterodimer with another protein, MD-2, and
uses a pocket in MD-2 to interact with the LPS of Gram-negative
bacteria (Kim et al., 2007b; Ohto et al., 2007; Park et al., 2009).mmunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc. 873
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Figure 1. Overall Structure of the Mouse TLR2-TLR6-Pam2CSK4
Complex
The TLR2, TLR6, and VLR fragments in the TLR-VLR hybrids are shown sche-
matically in light blue, light green, and gray, respectively. Pam2CSK4 is shown
in red. Some LRR modules are numbered and the N-terminal, central, and
C-terminal subdomains are labeled. (A) shows the side view; (B) shows the
top view.
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Crystal Structure of TLR2-TLR6-Diacyl LipopeptideAn exposed lipid chain of LPS and surrounding protein residues
mediate dimerization of the TLR4-MD-2 complex. Although
TLRs display little similarity in their ligand interactions, they all
adopt similar-lookingoverall arrangementsof the twomonomeric
subunits (Jin et al., 2007; Jin and Lee, 2008; Liu et al., 2008; Park
et al., 2009). In this ‘‘m’’-shaped dimeric structure, the carboxy
termini of the extracellular domains of the two TLRs converge
in the middle. Because the intracellular signaling domains are
connected to the carboxy termini of the extracellular domains,
convergence of the two carboxy termini can facilitate dimeriza-
tion of the intracellular TIR domains. Adaptor proteins, including
MyD88 and TRIF, which contain TIR domains, are known to be
recruited to the dimerized intracellular domains of TLRs, and
this initiates the immune response (O’Neill and Bowie, 2007).
TLR2 has themost complicated ligand-binding specificity in the
TLR family, partly because it can dimerizewith TLR1 or TLR6 (Gay
andGangloff, 2007; Jin et al., 2007). Although extensive biochem-
ical and structural research has been conducted for almost a
decade, our understanding of TLR2-ligand interactions is still
incomplete. To rectify this situation, we have determined the
crystal structuresof theTLR2-TLR6-diacylated lipopeptide,TLR2-
lipoteichoic acid, and TLR2-PE-DTPA complexes. PE-DTPA,
1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethylene-
triaminepentaacetic acid, is a synthetic derivative of phosphati-
dylethanolamine. Together with the previously reported structure
of the TLR1-TLR2-triacylated lipopeptide, these structures pro-
vide an explanation for why some lipopeptides interact only
with the TLR2-TLR1 heterodimer and others only with the TLR2-
TLR6 heterodimer.
RESULTS
Structure Determination and Overall Structure
of the TLR2-TLR6-Pam2CSK4 Complex
To improve protein production and crystallization, we fused the
extracellular domains ofmouse TLR2andmouse TLR6 to hagfish
variable lymphocyte receptor B (VLRB) clones 61 and59, respec-
tively, by using the hybrid LRR technique, as described previ-
ously (Jin et al., 2007; Kim et al., 2007b). VLRs are LRR family
proteins that function as adaptive immune receptors in jawless
fishes (Kim et al., 2007a; Pancer and Cooper, 2006). For mini-
mizing structural disturbance, TLR and VLR proteins were fused
at the conserved ‘‘LxxLxLxxN’’ sites while maintaining the
conservation pattern. In the TLR2-VLR hybrid, named mT2V6,
the last LRR module and the LRRCT module of TLR2 were re-
placed by VLRB.61 modules (Figure S1, available online). In the
TLR6-VLR hybrid, named mT6V10, the last two LRR modules
and the LRRCT module were replaced by the LRR and LRRCT
modules of the VLRB.59 clone. The fusion sites were located
more than 100 amino acids away from the ligand interaction
and receptor dimerization regions of the TLR complexes.
Although the TLR2 andTLR6 hybridswere purified asmonomeric
proteins, they formed a stable heterodimeric complexwhen incu-
bated with the synthetic diacylated lipopeptide Pam2CSK4 (Fig-
ureS2). TheTLR2-TLR6-Pam2CSK4complexwas further purified
by gel filtration chromatography and was crystallized for struc-
tural analysis.
LikehumanTLR1andTLR2,mouseTLR2andTLR6have20LRR
modules (Figures S3–S5). LRR modules have the ‘‘LxxLxLxxN’’874 Immunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc.motives that are responsible for the characteristic horseshoe-like
shape of the protein. Occasionally, the leucines are replaced by
hydrophobic residues, and asparagines are replaced by serines,
threonines, or cysteines (Bella et al., 2008; Matsushima et al.,
2007). These conserved motif regions are located in the parallel
b strands that constitute the concave surface of the horseshoe-
like structure. The variable regions of the modules are located on
the structurally diverse convex surface of the protein. The N and
C termini of the LRR modules are covered by the LRRNT and
LRRCT modules, respectively. The LRRNT and LRRCT modules
do not contain the ‘‘LxxLxLxxN’’ motives and protect the hydro-
phobic cores of the LRR modules from solvent exposure at both
termini. Structure and sequence conservation suggest that TLR2
and TLR6belong to the ‘‘typical’’ subfamily (Bella et al., 2008;Mat-
sushima et al., 2007). However unlike other LRR proteins, they
contain two structural transitions dividing the proteins into three
subdomains: N-terminal domain, central domain, and C-terminal
domain (Figure1A).Thestructuresof theN-terminaldomainclosely
resemble those of other typical subfamily proteins (Jin et al., 2007;
Jin and Lee, 2008; Kim et al., 2007b). However, the central and
C-terminal domains show substantial variations from the con-
sensus structures of the typical subfamily.
The ligand-binding site of TLR2 is composed of a large internal
pocket formed by hydrophobic residues from the LRR9-12
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Figure 2. The Lipopeptide-Binding Site of
the TLR2-TLR6 Complex
(A) The TLR2 and TLR6 residues involved in
Pam2CSK4 binding are drawn in blue and green,
respectively. Potential hydrogen bonds connect-
ing the TLRs and the ligand are shown by broken
red lines. F3430 and F3650 block the hydrophobic
channel in TLR6. The side chains of the peptide
and the glycerol moiety of Pam2CSK4 are shown
in pink. The peptide backbone and lipid chains
of Pam2CSK4 are shown in red and orange,
respectively.
(B) The TLR2 structures in the TLR2-TLR1-
Pam3CSK4andTLR2-TLR6-Pam2CSK4 complexes
were superimposed and the structures of
Pam2CSK4 and Pam3CSK4 were drawn. The shape
of the mouse TLR2 pocket in the TLR2-TLR6-
Pam2CSK4 structure is shown schematically by
broken lines.
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Crystal Structure of TLR2-TLR6-Diacyl Lipopeptidemodules and hydrophilic backbone atoms near the pocket-
opening located at the domain boundary between the central
and the C-terminal domains (Figure 1). TLR6 has 56% sequence
identity to TLR1, and their overall structures are very similar
(Figures S3–S5). However, large structural changes are found
in the ligand interaction and dimerization areas, which appear
to be responsible for the differences in their ligand-binding spec-
ificity and TLR dimerization characteristics. Dimerization of TLR2
and TLR6 is mediated by surface-exposed amino acids in their
LRR11-14 modules. As with other ligand-induced TLR homo-
or heterodimers, binding of Pam2CSK4 induces the formation
of an ‘‘m’’-shaped heterodimer of TLR2 and TLR6, in which the
N termini stretch out to opposite ends and the C-terminal tails
converge in the middle (Figure 1A). This dimeric arrangement is
found in all known TLR homo- or heterodimer structures and
supports the hypothesis that dimerization of the extracellular
domains enforces juxtaposition and activation of the intracellular
TIR domains (Jin et al., 2007; Liu et al., 2008; Park et al., 2009).
Throughout this article, single apostrophes are used for TLR1
and TLR6 residues and double apostrophes are used for peptide
residues of the lipopeptide to differentiate them from those of
TLR2.
The TLR2 Pocket Interacts with the Ester-Bound
Lipid Chains
The two ester-bound lipids of Pam2CSK4 are inserted through
a crevice formed between the LRR11 and LRR12 loops andImmunity 31, 873–884, Dinteract with the internal hydrophobic
pocket of TLR2 (Figure 2A). The position
of the crevice coincides with the
boundary between the central and
C-terminal domains, suggesting that a
structural transition at the domain
boundary is critical for pocket formation
(Figures S4 and S5). The volume of the
TLR2 pocket is 1200 A˚3, which is
15% bigger than the volume theoreti-
cally required for binding the two palmi-
toyl groups of the ligand. The lipid chainsin pocket have high structural mobility, with a 36% higher
average B factor than that of the protein residues in the pocket
area. The extra space in the pocket is responsible for the struc-
tural flexibility of the lipids because hydrophobic interaction is
relatively nonspecific and does not restrict the structure of the
lipids inside the pocket to a single and well-defined conforma-
tion. It also allows slight modifications of the chemical structure
and length of the ester-bound lipids of the ligands without seri-
ously impairing their ability to activate TLR2 (Buwitt-Beckmann
et al., 2005b).
The first half of the carbons in the two ester-bound lipid chains
has practically identical structures in the mTLR2-mTLR6-
Pam2CSK4 and hTLR2-hTLR1-Pam3CSK4 complexes (Fig-
ure 2B). However, the remaining half of the lipid carbons point
in different directions. This is due to sequence differences
between human and mouse TLR2s, as noted previously (Jin
et al., 2007). Among them, the F266L, L306P, L335T, and
F355L changes have substantial effects on the shape of the
pockets and therefore redirect the lipid chains inside the pockets
(Figure S6). Two lipid chains bound to a glycerol group are found
in a large number of reported TLR2 ligands (Zahringer et al.,
2008), and deletion or marked truncation of these two ester-
bound lipids completely abolishes TLR2 activation (Buwitt-
Beckmann et al., 2005b; Morath et al., 2005). Collectively, the
crystal structures and the biochemical data suggest that the
TLR2-lipid interaction is the main driving force for binding of
diacylglycerol-containing ligands including lipopeptides.ecember 18, 2009 ª2009 Elsevier Inc. 875
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Figure 3. Peptide and Glycerol Interactions
of Pam2CSK4 with TLR2 and TLR6
(A) Residues interacting with Pam2CSK4. Potential
hydrogen bonds are drawn in broken red lines and
their bond distances in angstroms are written
above the lines. Some residues make multiple
interactions with the ligand and are drawn more
than once.
(B) Structure of the LRR loops interacting with
Pam2CSK4 (left) and Pam3CSK4 (right). TLR2 is
colored light blue and TLR1 and TLR6 are in light
green. Potential hydrogen bonds are drawn with
broken red lines. NH and CO written below the
residue names refer to the backbone nitrogen
and oxygen atoms, respectively. The peptide
backbone and the lipid chains of the lipopeptides
are colored in red and orange, and the peptide
side chains and glycerol groups are shown in
pink. F3170 of TLR6, which corresponds to F3120
of TLR1 and undergoes a structural change, is
shown.
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Crystal Structure of TLR2-TLR6-Diacyl LipopeptideGlycerol and the Peptide Region of the Pam2CSK4
Ligand Interactwith Surface Residues of TLR2 and TLR6
The structures of the glycerol moiety and the peptide backbones
of the ligands in the TLR2-TLR1-Pam3CSK4 and TLR2-TLR6-
Pam2CSK4 complexes superimpose almost exactly (Figure 2B).
However, the structures of the interacting TLR residues undergo
several changes. The most important changes are concentrated
in the LRR11 loop of TLR6, which binds directly to the ligand
peptide group (Figure 3). The changes in LRR11 appear to be
triggered by a conformational shift of F3170. In the TLR2-TLR1-
Pam3CSK4 structure, the F312
0 residue of TLR1, which corre-
sponds to F3170 of TLR6, forms a hydrophobic wall together
with F3140, I3190, and Y3200 and points into the channel, thereby
interacting with the amide-bound lipid chain of the ligand (Fig-
ure 3B). The absence of the amide-bound lipid in the TLR2-
TLR6-Pam2CSK4 complex leads to a structural rearrangement
of this hydrophobic wall. The F3190, L3240, and Y3250 residues
of the TLR6 LRR110 loop, which correspond to F3140, I3190,
and Y3200 of TLR1, move further inside in order to fill the empty
channel, and as a result F3170 is pushed toward the outside of
the lipid channel. The movement of F3170 initiates a shift of the
TLR6 LRR110 loop to a position where it can form a new
hydrogen bond between the F3190 backbone and the first
peptide bond of the ligand. This hydrogen bond is absent from
the TLR2-TLR1-Pam3CSK4 structure (Jin et al., 2007).
Many hydrophilic interactions in the TLR2-TLR6-Pam2CSK4
complex are also found in the TLR2-TLR1-Pam3CSK4 complex.
For example, the hydrogen bonds between the glycerol and
peptide regions of the ligands and the D327 and F349 back-
bones of TLR2 are conserved (Figure 3). These shared interac-876 Immunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc.tions must play an important role in the
exceptionally strong TLR2 response
induced by di- and triacylated lipopro-
teins because these peptide head groups
are unique structural characteristics of
TLR2 lipoprotein ligands. The side chains
of the first two amino acids of Pam2CSK4
have substantial interactions with theTLRs. The amino-terminal cysteine binds to the ‘‘sulfur site’’
formed by the hydrophobic F325, L328, F349, L350, and P352
residues of TLR2 and the L3180 residue of TLR6 (Figure 3A).
The hydroxyl side chain of the second serine residue forms
a medium range hydrogen bond with the F325 backbone of
TLR2. As seen in the TLR2-TLR1-Pam3CSK4 structure, the
side chains beyond the third lysine residue have highly flexible
structures and form only weak ionic or hydrogen bond interac-
tions with the TLRs.
Enhanced Protein-Protein Interaction at the TLR2-TLR6
Dimerization Interface
Heterodimerization of TLR2 and TLR6 is mediated primarily by
the surface-exposed residues of the LRR11-14modules (Figures
4A and 4B). The LRR11 and LRR12 loops of TLR2 and TLR6 are
located in the center of the dimerization interface and provide
key hydrophobic residues. Hydrophilic residues surround and
support this hydrophobic interaction by forming ionic and
hydrogen bonds. As described above, the Pam2CSK4 ligand
also plays a bridging role because it interacts simultaneously
via several strong hydrogen bonds with both TLR2 and TLR6
(Figure 3).
In TLR1-TLR2 heterodimerization, the amide-bound lipid chain
has an indispensable role by bridging the two TLRs. Although
Pam2CSK4 lacks the amide-bound lipid chain, it nonetheless
induces the formation of a stable heterodimer of TLR2 and
TLR6 (Figures S7 and S8), which suggests that the TLR2-TLR6
complex has a stronger protein-protein interaction. The crystal
structure supports this hypothesis in the following ways: (1) the
total area of the hydrophobic core of the dimerization interface
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Figure 4. The Heterodimerization Interface
of the TLR2-TLR6-Pam2CSK4 Complex
(A) The TLR2 and TLR6 structures in the heterodi-
meric complex have been split and rotated by
90 to show the dimerization interface. The lipid
chains, glycerol, and peptide backbone of
Pam2CSK4 are shown in orange, pink, and red,
respectively. TLR2 and TLR6 are in blue and green,
respectively. The hydrophobic residues of the
interface are drawn in lighter colors, whereas resi-
dues involved in hydrogen or ionic bonds are in
darker colors.
(B) Residues involved in TLR2 and TLR6 dimeriza-
tion are linked by broken lines.
(C) The hydrophobic core of the TLR6 dimerization
interface in the TLR2-TLR6 complex and that of the
TLR1 interface in the TLR1-TLR2 complex are
shown in red (left) and green (middle), respectively.
The two figures are merged in the right panel. The
hydrophobic interface unique to the TLR2-TLR6
dimer is labeled in the right panel.
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Crystal Structure of TLR2-TLR6-Diacyl Lipopeptideof TLR6 is increased by 80% compared to that in TLR1 (Fig-
ure 4C). Residues F3170, L3180, P3420, V3470 of TLR6makemajor
contributions to the increased hydrophobic dimerization inter-
face. The F3170, L3180, and V3470 residues of TLR6 are either
conserved or conservatively changed relative to other species
(Figure S9). (2) Several other interactions also enhance TLR2-
TLR6 dimerization. For example, V3080 of TLR1 is changed to
a lysine in TLR6. This K3130 forms a strong ionic interaction with
E375 of TLR2 (Figure 4B), and D3400 of TLR6 provides an addi-
tional interaction with TLR2 not seen in the TLR1-TLR2 dimeriza-
tion interface.
The Lipid-Binding Channels in TLR1 and TLR6
Determine Lipopeptide Specificity
The TLR1 channel is used for binding the amide-bound lipid
chain of the triacylated lipopeptide (Jin et al., 2007). The corre-
sponding lipid-binding channel in TLR6 is less than half as long
as that of TLR1 (Figure 5A). Truncation of the channel explains
why the TLR2-TLR6 complex has markedly reduced affinity for
and response to triacylated lipopeptides. The lipid-binding
channel of TLR6 is shortened by the bulky side chains of F3430Immunity 31, 873–884, Dand F3650 that block the channel in the
middle (Figure 5B). These evolutionarily
conserved residues collide with the C11
carbon of the amide-bound lipid chain if
a triacylated lipopeptide is modeled into
the TLR2-TLR6 structure (Figure 5A and
Figure S9).
Toconfirm theproposed roleof the trun-
cated TLR6 channel in ligand specificity,
we performed site-directed mutagenesis
experiments on residues comprising
the lipid channel. To assess the responses
of TLR6 mutants to lipopeptides, we
measured IL-8 reporter activities after lip-
opeptide treatment by using SW620 colo-
rectal cell line cotransfected with TLR1and TLR2 or with TLR2 and TLR6. Wild-type TLR2-TLR6 gave
no response to Pam3CSK4. However, TLR2 cotransfected with
TLR6 mutants harboring the F3430M mutation gave small
increases in response to Pam3CSK4 at 200 ng/ml (Figure 5C).
Furthermore, the double substitution of TLR6, F3430M, and
F3650L, gave an almost complete response (Figures 5C and
5D). Control TLR6s with the L3180G, S3200P, and F2700L muta-
tions barely gave any response to Pam3CSK4, demonstrating
the specificity of the effect of the F3430M and F3650L mutations.
In the crystal structure, F3430 directly blocks the lipid channel
(Figure 5B). F3650 is located right behind F3430 and has a role in
fixing the conformation of the F3430 side chain. Therefore, simul-
taneous substitution of F3430 and F3650 is necessary for gener-
ating a functional lipid channel. The fact that the Pam2CSK4
response of the mutated TLR6 was not changed compared to
that of wild-type TLR6 suggests that the structure of the TLR2-
TLR6-Pam2CSK4 complex was not seriously affected by the
double substitution (Figure 5E). Omueti et al. have previously
reported domain-exchange experiments between TLR1 and
TLR6. They showed that the LRR9-12modules of TLR6 are indis-
pensable for discrimination between tri- and diacylatedecember 18, 2009 ª2009 Elsevier Inc. 877
A 
Pam2CSK4
K ’’
K6’’ Pam3CSK4
K ’’
K6’’
mTLR2 pocket
K3’’K4’’
5
mTLR6 channel
hTLR2 pocket
hTLR1 channel
K3’’
K4’’ 5
S2’’C1’’
S2’’
C1’’
Pam2CSK4
mTLR6LRR10’
CB
20
15
None
Pam3CSK4
ct
iv
ity
 
H2’H3’L318’(G313’)
10
5
R
e
la
tiv
e 
Lu
ci
fe
ra
se
 A
c
I344’(V339’)
F365’(L360’)
I338’(V333’)
0
R
D E
None
Pam2CSK4
6
8
10
se
 A
ct
iv
ity
 
se
 A
ct
iv
ity
 
20
15
vector
TLR2
TLR2-TLR6
TLR2-TLR1
TLR2-TLR6(F343M/F365L)
**
**
***
**
* *
*
2
4
R
el
av
tiv
e 
Lc
ife
ra
s
R
el
at
iv
e 
Lu
ci
fe
ra
s
10
5
00
0 20 50 200 5001
Pam3CSK4 (ng/ml)
Figure 5. Mutagenesis of the TLR6 Channel
(A) The Pam2CSK4 binding pocket in the mTLR2-
TLR6 complex (left) and the Pam3CSK4-binding
pocket in the hTLR1-TLR2 complex (right) are
represented in mesh. The molecular surfaces
belonging to TLR2 and TLR6 or TLR1 are colored
blue and green, respectively. Pam2CSK4 and
Pam3CSK4 are colored as in Figure 2A.
(B) Residues that differ between the mTLR6 and
hTLR1 channels are shown. TLR6 residues are
labeled and the corresponding TLR1 residues are
written in parentheses. The phenylalanines F3430
and F3650 that block the hydrophobic channel of
mTLR6 are colored red.
(C) SW620 cells were transiently transfected with
various combinations of TLR1 (T1), TLR2 (T2), and
TLR6 (T6) wild-type or mutant plasmids as indi-
cated, along with reporter plasmids. Forty eight
hours after transfection, cells were treated with
carrier or 200 ng/ml Pam3CSK4 for an additional
6 hr and subjected to luciferase assay as described
in Experimental Procedures. The reporter data are
means ± SE. Similar results were obtained in more
than three independent experiments.
(D) Transient transfection was performed with the
indicated plasmids. Cells were incubated with
0500 ng/ml Pam3CSK4 for 6 hr and subjected to
luciferase assay as described in the Experimental
Procedures. The data represent means ± SE.
(E) Transient transfection followed by luciferase
assay was performed as in (C). Twenty-four hours
after transfection, cellswere incubatedwith 200ng/
ml Pam2CSK4 for an additional 6 hr. Reporter activ-
itiesof all theTLR2-TLR6wild-typeandmutantcon-
structs show statistically significant changes from
that of TLR2alone. The data representmeans ± SE.
*p < 0.05, **p < 0.01, and ***p < 0.001.
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Crystal Structure of TLR2-TLR6-Diacyl Lipopeptidelipopeptides (Omueti et al., 2005). This is mainly because the
F3430 residue resides in the LRR12 loop of TLR6. On the basis
of these structure and the mutational analyses, we conclude
that the response to triacylated lipopeptides is impaired in
TLR2-TLR6 because the amide-bound lipid chain is too long to
fit into the short TLR6 lipid channel.
Structural Comparison with the TLR2-Streptococcus
pneumoniae LTA Complex
To study the effects of the head groups of lipopeptides on ligand
binding and dimerization, we determined the crystal structures
of TLR2 in complex with two nonpeptide ligands, Streptococcus
pneumoniae lipoteichoic acid (pnLTA) and PE-DTPA. The latter is
a synthetic derivative of phosphatidylethanolamine in which
a metal-coordinating DTPA group is attached to the ethanol-
amine head group. LTA is a membrane glycolipid of Gram-posi-
tive bacteria that has a diacylated glycerol group attached to a
sugar backbone and repeating units. The head groups of LTA878 Immunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc.derived from different bacterial species
display significant structural differences
(Figure S2B). Using hybrids of the extra-
cellular domains of TLR with VLR frag-
ments, we found that pnLTA binds to
TLR2with high affinity but it cannot induceheterodimerization of the extracellular domains of TLR1-TLR2 or
TLR2-TLR6 (Figures S10 andS11). This observation is consistent
with the substantially weaker proinflammatory activity of pnLTA
compared with lipoproteins or Staphylococcus aureus LTA (Han
et al., 2003). We have been able to crystallize the complex of
the mT2V6 hybrid and pnLTA and have determined its structure.
In the monomeric TLR2-pnLTA structure, the overall horse-
shoe-like shape and structure of the lipid-binding pocket is
not changed (Figure 6A). However, the structures of the LRR10
and LRR11 loops of TLR2, and position of the ligand head
group, are substantially altered from those in the TLR2-TLR6-
Pam2CSK4 and TLR2-TLR1-Pam3CSK4 structures (Figures 6B–
6D). In the TLR2-TLR6-Pam2CSK4 and TLR2-TLR1-Pam3CSK4
structures, the LRR11 loops are folded toward the ligand, form-
ing multiple hydrogen bonds with it. In the TLR2-pnLTA struc-
ture, the position of the sugar head group of LTA are translated
by 5.2 A˚ and rotated by 110 toward the lateral surface of
the horseshoe-like structure (Figures 6C and 6D). Because of
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Figure 6. Structural Comparison of the
mTLR2-LTA and mTLR2-TLR6-Pam2CSK4
Complexes
(A) The structure of the mouse TLR2 and S. pneu-
moniae LTA complex is shown schematically. The
TLR2 and VLR fragments in the mT2V6 hybrid are
colored blue and gray, respectively. The lipid
chains, glycerol, and sugar groups of the bound
LTA are in orange, pink, and red, respectively. The
head group of LTA apart from the first two sugars
is not clearly visible in the electron density map,
presumably because of the great flexibility of the
structure. The TLR2 residues interacting with LTA
are shown. Disulfide bridges are colored yellow.
(B) Comparison of the TLR2 structures in the TLR2-
TLR6-Pam2CSK4 and TLR2-LTA complexes. The
two TLR2 structures are aligned and their Ca
traces are superimposed. The H2 helix of LRR9 is
omitted for clarity.
(C) The structures of Pam2CSK4 and LTA are
drawn after alignment of the TLR2 structures
in the TLR2-TLR6-Pam2CSK4 and TLR2-pnLTA
complexes. The TLR2 pocket in the TLR2-TLR6-
Pam2CSK4 complex is drawn with broken lines.
The chemical structures of pnLTA and Pam2CSK4
are shown on either side. The lipid chains of LTA
are heterogeneous in length and chemical struc-
ture, and one representative chemical structure is
shown. Some of the carbons in the lipid chains of
LTA are not visible in the electron density map
presumably because of the extensive atomic
mobility and/or chemical heterogeneity and are
indicated by broken lines (see Figure S15).
(D) Surface rendering of the entrance of TLR2
pockets with bound pnLTA (left) and Pam2CSK4
(right). LTA and Pam2CSK4 are colored blue and
red, respectively. The lipid and glycerol moieties
of the ligands are drawn in lighter colors.
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Crystal Structure of TLR2-TLR6-Diacyl Lipopeptidethis shift, the interaction between the ligand head group and the
D327 and F349 backbones of LRR11 present in the TLR2-TLR1-
and TLR2-TLR6-lipopeptide complexes is completely disrupted
in the TLR2-pnLTA structure.
It appears that twomajor factors are responsible for this struc-
tural change: (1) The sulfur atom of the amino terminal cysteine of
the lipopeptide is replaced by an oxygen in the pnLTA sugar
backbone. Because the cysteine side chain interacts with a
hydrophobic binding site formed by TLR2 and TLR6 residues
(Figure 3A), the hydrophilic oxygen atomof pnLTAwill be repelled
away from thesulfur site. The sulfur interaction site hasa substan-
tial effect on theTLR2 responsebecauseevenchanging thesulfurImmunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc. 879to a hydrophobic carbon reduces the
activity of the lipopeptide by 75%
(Spohn et al., 2004). (2) More importantly,
the sugar head group of pnLTA has a
different arrangement of hydrogen donor
and acceptor atoms from those of the
lipopeptides. Therefore, it cannot form a
hydrogen bonding network such as the
lipopeptideheadgroupsdo. Thehydrogen
bonds are crucial for fixing the conforma-
tion of the LRR11 loops and hence forforming an effective TLR2 and TLR6 dimerization interface. The
importance of these head group interactions is further illustrated
by the TLR2-PE-DPTA complex, in the following section.
Structural Comparison with the TLR2-PE-DTPA
Complex
PE-DTPA, a synthetic compound with two lipid chains, can bind
strongly to TLR2 but cannot induce the formation of TLR2-TLR1
or TLR2-TLR6 heterodimers (Figures S12 and S13). We have
studied the structure of the TLR2-PE-DTPA complex to confirm
the importance of the head group interactions in ligand-induced
heterodimerization of TLR2. The structure also gives a clue to
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Figure 7. Structural Comparison of the
TLR2-PE-DTPA and TLR2-TLR6-Pam2CSK4
Complexes
(A) Schematic structure of the mouse TLR2-PE-
DTPA complex. The TLR2 and VLR fragments in
the mT2V6 hybrid are colored blue and gray,
respectively. The lipid chains, glycerol, and head
groups of the bound PE-DTPA are colored orange,
pink, and red, respectively. The TLR2 residues in-
teracting with PE-DTPA are shown in dark blue.
Part of the LRR10 and LRR11 loops are not visible
in the electron density map because of the great
flexibility and are indicated by broken lines.
(B) Comparison of the TLR2 structures in the
TLR2-TLR6-Pam2CSK4 and TLR2-PE-DTPA
complexes. The two TLR2 structures are aligned
and their Ca traces are superimposed. The H2
helix of LRR9 is omitted for clarity.
(C) Structures of Pam2CSK4 and PE-DTPA drawn
after alignment of the TLR2 structures in the
TLR2-TLR6-Pam2CSK4 and TLR2-PE-DTPA
complexes. The TLR2 pocket in the TLR2-TLR6-
Pam2CSK4 complex is shown by broken lines.
The last several carbons of the lipid chains of PE-
DTPA are indicated by broken lines because they
were excluded from the final structure as a result
of the great structural flexibility (Figure S15).
(D) Surface rendering of the entrance of the TLR2
pockets with bound PE-DTPA (left) and
Pam2CSK4 (right). PE-DTPA and Pam2CSK4 are
colored green and red, respectively. Lipid and
glycerol moieties of the ligands are drawn in
lighter colors. Part of the LRR11 loop in the
TLR2-PE-DTPA structure is not included in the
final model because of flexibility and is indicated
by broken lines.
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Crystal Structure of TLR2-TLR6-Diacyl Lipopeptidewhy the abundant phospholipids in the human body do not acti-
vate the TLR2 pathway.
In the crystal structure, the overall conformation of TLR2 is not
changed from that in the other TLR2-ligand complexes, and the
two acyl chains of PE-DTPA are inserted into the TLR2 pocket as
in the other TLR2-ligand complexes (Figure 7A). However, the
structure of the LRR11 loops and positions of the ligand head
group are changed in a similar fashion to that seen in the
TLR2-pnLTA complex. The position of the PE-DTPA head group
is shifted 4.3 A˚ toward the LTA head group in the TLR2-pnLTA
complex, and thehydrogenbondsbetween the ligandheadgroup
and TLR are also disrupted (Figures 7B–7D). As discussed above880 Immunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc.for the TLR2-pnLTA complex, this struc-
tural shift of the head group is probably
due to lack of proper hydrogen bonding
between ligand and TLRs and the repul-
sion of the oxygen atom from the hydro-
phobic sulfur site of TLRs. The fact that
both pnLTA and PE-DTPA, with little or
no ability to activate TLR2, use similarly
shifted binding sites strongly suggests
that the head group interactions play an
important role in TLR2 activation by heter-
odimerization (Figure S14; Han et al.,
2003). Of themany TLR2 ligands, lipopep-tides show the strongest TLR2 stimulatory activity (Zahringer
et al., 2008), probablybecause they inducestableheterodimeriza-
tionof theextracellular domainsof TLR2andTLR1orTLR6. This is
due, at least in part, to the interaction provided by the peptide
head groups, which play critical roles in maintaining the bound
ligand structure suitable for TLR heterodimerization.
DISCUSSION
The interactions between the lipopeptide and the TLR2-TLR6
or TLR2-TLR1 heterodimer can be divided into four different
types.
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Crystal Structure of TLR2-TLR6-Diacyl LipopeptideFirst, hydrophobic interaction between the two ester-bound
lipids and the TLR2 pocket appears to be the major driving force
for TLR2 binding. The observation that LTA and PE-DTPA, which
lack peptide head groups, nevertheless have a high affinity for
TLR2 supports this hypothesis. Two lipid chains with at least
12 carbons in human TLR2, or eight carbons in mouse TLR2,
appear to be necessary for achieving a strong TLR2 response
to the lipopeptides (Buwitt-Beckmann et al., 2005b). Double
bonds are allowed in the lipid chains. This hydrophobic interac-
tion is strong, but it is a relatively nonspecific interaction and not
seriously disturbed by small changes in lipid length or chemical
structure.
Second, hydrogen bonds between glycerol and the peptide
backbone of the ligand and the LRR11 loops of TLRs are critical
for TLR heterodimerization. These hydrogen bonds not only
bridge TLR2 and TLR6 by simultaneously interacting with the
ligand but also play a key role in fixing the conformation of the
hydrophobic residues located in the center of the dimerization
interface. LTA and PE-DTPA do not have a peptide head group
and therefore cannot provide the head group interaction neces-
sary for heterodimerization of the TLR extracellular domains, at
least under our experimental conditions.
Third, the interaction between the amide-bound lipid chain
and the TLR1 channel is essential for the TLR2-TLR1 response
to triacylated lipopeptides. For a robust response, the amide-
bound lipid chain should have at least eight carbons (Buwitt-
Beckmann et al., 2005b). Pam2CSK4 lacking the amide-bound
lipid has substantially lower affinity for TLR1-TLR2 and cannot
induce stable heterodimerization of the isolated extracellular
domains of TLR1 and TLR2 in our experimental conditions. As
discussed in the Results, TLR2-TLR6 has a reduced affinity for,
and response to, triacylated lipopeptides because TLR6 does
not have a proper binding site for the amide-bound lipid. The
increased hydrophobic area of the TLR2-TLR6 interface appears
to compensate for the lack of interaction between the amide-
bound lipid and the TLR6 channel in the TLR2-TLR6-diacylated
lipopeptide complex. Therefore, the diacylated lipopeptide can
still induce stable binding and dimerization of TLR2-TLR6.
Fourth, the peptide side chains except for the first cysteine
play a relatively minor role in TLR2 binding and TLR2-TLR6
and TLR2-TLR1 heterodimerization. This structural analysis is
consistent with the data on sequence conservation in bacterial
lipoproteins. The first cysteine is completely conserved, and
small amino acids are preferred in the second residue, but the
residues beyond the third are not detectably conserved (Madan
Babu and Sankaran, 2002). The first cysteine is conserved not
only because it is the site of covalent attachment of the diacylgly-
cerol group but also because its side chain interacts with the
hydrophobic sulfur site. The second serine residue fits into
the narrow neck area of the ligand-binding pocket formed by
the LRR11 loops of TLR2 and TLR6.
All four types of interaction described above cooperate in the
binding and dimerization of TLR2-TLR1 and TLR2-TLR6. For
example, a reduction in one kind of interaction can be compen-
sated for by an increase in another type of interaction, as shown
in the series of papers published by Ulmer and coworkers
(Buwitt-Beckmann et al., 2005a; Buwitt-Beckmann et al., 2006;
Buwitt-Beckmann et al., 2005b; Spohn et al., 2004). Although
amino acid residues beyond the second serine in Pam2CSK4Iand Pam3CSK4 have only opportunistic interactions with TLRs
in the crystal structures, they are still located within 5 A˚ of the
TLRs and can interact substantially with TLRs if the amino acid
sequences in other lipopeptides or lipoproteins allow it. These
interactions, although weak, can have a role in modulating the
immunologic response and the choice of TLR2 heterodimer.
Some diacylated lipopeptides or lipoproteins have a strong pref-
erence for either TLR2-TLR1 or TLR2-TLR6. This can be ex-
plained if their peptide regions form specific interactions with
TLR1 or TLR6. Okusawa et al. (2004) measured the TNF-a
response of HEK293 cells transfected with TLR2 and TLR6 after
treatment with several MALP-2 derivatives. FSL-1 has an iden-
tical diacylglycerol structure but different peptide sequence to
MALP-2. FSL-2 has a chemical structure completely identical
with FSL-1 except that the C-terminal phenylalanine is changed
to an arginine. They found that FSL-1 treatment generated a
4-fold greater TNF-a response than MALP-2. Changing the
C-terminal amino acid of FSL-1 to that of FSL-2 reduced the
cellular response by 20%. Buwitt-Beckmann et al. (2005a)
described the responses to different lipopeptides in transfected
HEK293 cells (Buwitt-Beckmann et al., 2005a). They found that
Pam2CSK4 gave a stronger signal than MALP-2. Pam2CSFEPP-
PATTT had the weakest activity of the three lipopeptides. These
data clearly demonstrate that the peptide sequences can have
a detectable effect on the immunological activity of lipopeptides.
TLR2 heterodimers display complex ligand specificity when
they are bound to membranes in a cellular environment. Initially,
it was proposed that the TLR2-TLR1 complex was specifically
stimulated by triacylated lipopeptides, and the TLR2-TLR6
complex was stimulated only by diacylated lipopeptides (Takeu-
chi et al., 2001; Takeuchi et al., 2002). Later, it was found that
some synthetic diacylated lipopeptides including Pam2CSK4,
Pam2CSE4 and MALP-SK4 could initiate substantial signals
even in TLR6-deficient cells, presumably via the TLR2-TLR1
complex (Buwitt-Beckmann et al., 2005a). This functional anal-
ysis with full-length TLRs in cell membranes appears at first to
contradict our in vitro results because the isolated extracellular
domains of TLR2 and TLR1 did not form heterodimers with
Pam2CSK4 in our experiments. The discrepancy may be
explained by the fact that the diffusion of proteins anchored to
membranes is severely restricted, and thus even weak interac-
tions can induce multimerization of the proteins. Pam2CSK4
without an amide-bound lipid chain cannot provide enough inter-
action energy to induce dimerization of the extracellular domains
of TLR2 and TLR1 detached from cellularmembrane. However, it
probably provides enough interaction energy to induce dimeriza-
tion of full-length TLR2 and TLR1 in a membrane environment.
Nevertheless, as shown in our in vitro binding assays, the affinity
of Pam2CSK4 for TLR2-TLR6 must be substantially higher than
for the TLR2-TLR1 complex. Therefore Pam2CSK4 should be
mainly recognized by the TLR2-TLR6 complex in cells containing
both TLR1 and TLR6, although the Pam2CSK4 signal can be
mediated by TLR2-TLR1 in cells deficient of TLR6. Our biochem-
ical and structural results show that S. pneumoniae LTA cannot
induce heterodimerization of the isolated extracellular domains
of TLR2 with TLR1 or TLR6. However, this observation also
does not exclude the possibility that it may induce dimerization
of full-length TLR2 with TLR1 or TLR6 in membrane-attached
conditions.mmunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc. 881
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Crystal Structure of TLR2-TLR6-Diacyl LipopeptideThe S. pneumoniae LTA has head group structures different
from that of S. aureus LTA. The conserved backbone of S. pneu-
moniae LTA is composed of glucose-AATGal-glucose sugar
chains. The variable unit containing a ribitol-phosphate, two Gal-
NAc, an ATTGal, and a glucose group is typically repeated six to
eight times (Behr et al., 1992; Seo et al., 2008). LTA from
S. aureus also has the diacylated glycerol moiety but its sugar
backbone and the repeating units have completely different
structures (Morath et al., 2005; Stadelmaier et al., 2006). Previ-
ously, several laboratories have reported that S. aureus LTA
strongly activates the NF-kB pathway via TLR2 (Opitz et al.,
2001; Ryu et al., 2009; Schwandner et al., 1999), although
some of the later reports have yielded contradictory results (Ha-
shimoto et al., 2006a; Hashimoto et al., 2006b). TLR2 response
of S. pneumoniae LTA is shown to be only 1% compared to
that of S. aureus LTA (Han et al., 2003). Therefore, it is possible
that the two LTAs with different structures may have different
recognition pathways as well. The controversy over the immuno-
logical activity of various LTAs needs to be clarified for a proper
biological interpretation of the TLR2-pnLTA structure presented
in this article.
A large proportion of TLR2 ligands contain lipid chains that can
be inserted into the TLR2 pocket for binding. However, some
TLR2 ligands including peptidoglycan, low-molecular-weight
hyaluronic acid, versican, teichoic acid, and zymosan have
apparently no hydrophobic regions for TLR2 binding. Therefore,
the interaction of these ligandswith TLR2 heterodimersmust use
different binding sites. Nevertheless, because all TLR-ligand
complexes have a similar ‘‘m’’-shaped dimeric structure and all
TLRs except TLR3 need to interact with MyD88 to initiate intra-
cellular signaling, it is very likely that even non-lipid-containing
ligands of TLR2 induce the formation of similar heterodimeric
structures of TLR2-TLR1 or TLR2-TLR6.
In summary, we have determined the crystal structures of the
TLR2-TLR6-diacylated lipopeptide complex and of complexes
of TLR2 with nonpeptide ligands. These structures together
with the previously reported TLR2-TLR1 structure reveal the
contributions of various parts of the ligand structures to ligand
specificity and the activation of TLR2 heterodimers. On the basis
of the structural and biochemical analyses, we conclude that the
lipid chains provide themain binding energy and that the peptide
head group is required to form the stable TLR2 heterodimers and
initiate the strong inflammatory signal.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The mT2V6 hybrid generated by fusion of the ectodomain of mouse TLR2 (M1-
I506) and the hagfish VLRB.61 (N133-T200) was cloned between the XbaI and
NotI sites in the pVL1393 baculovirus transfer vector (BD Biosciences). The
mT6V10 hybrid was generated by combining the ectodomain of mouse TLR6
(M1-V480) and the hagfish VLRB.59 (N157-T232) and was cloned between
the BamHI and NotI sites of the same vector. The Fc domain of human IgG1
was tagged between the NotI and BglII sites of the vector, and a thrombin
cleavage site was introduced between the hybrid gene and the Fc domain.
The sequences of the cloned hybrid genes were confirmed by DNA
sequencing. All Fc-tagged TLR-VLR hybrids were expressed in High Five
insect cells (Invitrogen) and purified by protein A agarose chromatography
(Peptron). After cleavage by thrombin to remove the Fc tag, the hybrid proteins
were purified by ion exchange chromatography. A HiTrap Q (GE Healthcare
Life Sciences) anion exchange column was used for the mT2V6 hybrid, and882 Immunity 31, 873–884, December 18, 2009 ª2009 Elsevier Inc.HiTrap SP (GE Healthcare Life Sciences) cation exchange chromatography
was used for the mT6V10 hybrid. Approximately 100 mg of purified TLR hybrid
proteins could be obtained from 1 liter of the insect cell culture.
Ligand Binding to TLR2 or the TLR2-TLR6 Complex
For generation of the TLR2-TLR6-Pam2CSK4 complex, 5 mg/ml of the
synthetic R-isomer of Pam2CSK4 (EMC Microcollections) was incubated
with 3 mg/ml of purified mT2V6 hybrid protein at room temperature for
30 min in a buffer containing 20 mM Tris-HCl (pH 8.0) and 200 mM NaCl.
Then, purified mT6V10 in 1:1 molar ratio with mT2V6 was added to the mixture
and incubated for another 30 min at room temperature. For generation of the
TLR2-pnLTA and TLR2-PE-DTPA complexes, 1.5 mg/ml of S. pneumoniae
LTA or 1 mg/ml of PE-DTPA (Avanti Polar Lipids) was incubated with 3 mg/
ml of purified mT2V6 hybrid protein at room temperature for 30 min in a buffer
containing 20 mM Tris-HCl (pH 8.0) and 200 mM NaCl. Highly pure and struc-
turally intact LTAwas prepared from S. pneumoniaeR36A strain (ATCC 27336;
American Type Culture Collection) by organic solvent extraction followed by
hydrophobic-interaction and ion-exchange chromatography as described
previously (Han et al., 2003). The molar ratios of Pam2CSK4, pnLTA and
PE-DTPA to the protein in the binding reactions were 5:1, 1.2:1, and 5:1,
respectively. The protein-ligand complexes were further purified by Superdex
200 gel filtration chromatography (GE Healthcare Life Sciences) and concen-
trated to 5 mg/ml for crystallization.
Crystallization and Data Collection
All the protein complexes were crystallized at 23C by the hanging-drop vapor
diffusion method. Crystals of the mT2V6-mT6V10-Pam2CSK4 complex were
obtained by mixing 2 ml of protein solution with 2 ml of reservoir solution con-
taining 2.0 M ammonium sulfate and 0.1 M MES (pH 5.5). For data collection,
crystals were transferred to a cryo-protective solution with 30% glycerol
added to the crystallization solution. The mT2V6-pnLTA complex was crystal-
lized with a solution containing 50 mM ammonium citrate (pH 7.0), 20% PEG
4000, and 30% ethylene glycol. The mT2V6-pnLTA crystals were frozen with
the crystallization buffer as the cryo-protective solution. The mT2V6-PE-
DTPA complex was crystallized with a solution containing 0.2 M ammonium
sulfate, 0.1 M Na-HEPES (pH 7.5), and 25% PEG 4000 and transferred to
a cryo-protective solution containing 0.2 M ammonium sulfate, 0.1 M
Na-HEPES (pH 7.5), and 45% PEG 4000. All crystals were flash-frozen in
boiling liquid nitrogen at 170C. Diffraction data were collected at the 4A
beam line of the Pohang Accelerator Laboratory, the BL41XU beam line of
SPring-8, and the ID23-2 beam line of ESRF. The HKL2000 (HKL Research)
and the XDS program package (Kabsch, 1993) were used for indexing, inte-
grating, and scaling the diffraction data (Table S1).
Structure Determination
The initial phases were calculated by molecular replacement with the program
PHASER (McCoy et al., 2005). The crystallographic statistics and the search
probes used for the molecular replacement calculations are summarized in
Table S1. The atomic models were built by iterative modeling and refined
with the programs O, CNS, and PHENIX (Adams et al., 2002; Brunger et al.,
1998; Jones et al., 1991). The atomic models of the ligands were built into
the strong and continuous electron density found in the 2Fo-Fc and Fo-Fc
electron density maps (Figure S15). Residues 294–305 and 322–327 of
mT2V6-PE-DTPA were not clearly visible in the electron density map and
were excluded from the final model. No nonglycine residues were found in
the disallowed region of the Ramachandran plot.
Transient Transfection and IL-8 Reporter Assays
The transfection experiments were performed as previously described (Omueti
et al., 2005). SW620 colorectal cells were transfected with various combina-
tions of human TLR1, TLR2, and TLR6, CD14 expression plasmids, a reporter
plasmid driven by IL-8 promoter, and pRL-TK, an internal control plasmid ex-
pressing the Renilla luciferase gene (Promega). Transfections were performed
with Transfectin lipid reagent (Bio-Rad). After 24–48hr, the cellswere incubated
with the lipopeptide ligands for an additional 6 hr. Pam3CSK4 and Pam2CSK4
werepurchased fromEMCMicrocollections.FireflyandRenilla luciferase activ-
ities in cell lysates were measured sequentially with a Dual-Luciferase reporter
Immunity
Crystal Structure of TLR2-TLR6-Diacyl Lipopeptideassay system (Promega) with a VICTOR3 multilabel reader (Perkin Elmer Life
Sciences).
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